7701 - 7710 of 8586 Results
Title
Year
- Die Vermehrung von Alpha‐Synuclein Amyloidfibrillen ist unterdrückt unter vollständig ruhenden Lösungsbedingungen2024RESTRICTEDTitle: Die Vermehrung von Alpha‐Synuclein Amyloidfibrillen ist unterdrückt unter vollständig ruhenden LösungsbedingungenJournal Name: Angewandte ChemiePublisher: WileyVol: 137Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ange.202419173Best OA location URL: https://doi.org/10.1002/ange.202419173Citation Count: 0
-
OPENTitle: PINK1 regulated mitophagy is evident in skeletal musclesJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1080/27694127.2024.2326402Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2024.2326402?needAccess=trueCitation Count: 11
-
OPENTitle: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 5Start Page: 2109End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982Citation Count: 61
-
OPENTitle: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 88Issue #: 8Start Page: 653End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282477Citation Count: 95
- Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s model2025OPENTitle: Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson’s modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01049-1Best OA location URL: https://www.nature.com/articles/s41531-025-01049-1.pdfCitation Count: 0
- N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine2024OPENTitle: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholineJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.97228.3Best OA location URL: https://cdn.elifesciences.org/articles/97228/elife-97228-v1.pdfCitation Count: 1
- Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease2021OPENTitle: Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00260-0Best OA location URL: https://www.nature.com/articles/s41531-021-00260-0.pdfCitation Count: 29
- Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition2017OPENTitle: Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque depositionJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1864Issue #: 1Start Page: 208End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2017.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5875988Citation Count: 63
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
RESTRICTEDTitle: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 32Issue #: 6Start Page: 710End Page: 720Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11096064Citation Count: 6